Nepafenac loaded silica nanoparticles dispersed in-situ gel systems: Development and characterization

被引:21
作者
Paulsamy, Muthuselvam [1 ]
Ponnusamy, Chandrasekar [2 ]
Palanisami, Mohananarayanan [2 ]
Nackeeran, Gayathri [2 ]
Paramasivam, SivaSakthi [2 ]
Sugumaran, Abimanyu [3 ]
Kandasamy, Ruckmani [2 ]
Natesan, Subramanian [2 ]
Palanichamy, Rajaguru [1 ]
机构
[1] Anna Univ, Dept BioTechnol, Univ Coll Engn, BIT Campus, Tiruchirappalli, Tamil Nadu, India
[2] Anna Univ, Dept Pharmaceut Technol, Univ Coll Engn, BIT Campus, Tiruchirappalli, Tamil Nadu, India
[3] SRM Univ, Dept Pharmaceut, Kattankulathur, Tamil Nadu, India
关键词
Nepafenac; Silica nanoparticles; In-situ gel; DRUG-DELIVERY; POLOXAMER GEL; CHITOSAN; OPTIMIZATION; PERMEABILITY; COMPLEXES; CHITIN;
D O I
10.1016/j.ijbiomac.2018.01.123
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This research was aimed to develop and evaluate nepafenac loaded silica nanoparticles dispersed in situ gel system for the improved treatment of ocular diseases. The blank silica nanoparticles prepared by stober's process showed the particle size of 151 nm to 285 nm with the zeta potential of -19.6 to -31.9 mV. The nepafenac loaded silica nanoparticles were spherical in shape with smooth outer surface. The nepafenac loaded silica nanoparticles dispersed in poloxamer - chitosan in-situ gelling system showed gelling temperature of 32 degrees C with sustained release of nepafenac and higher permeation (58.79 mu g) across the goat cornea than poloxamer - poloxamer (21.18 mu g) in-situ gelling system. Hence the developed in-situ gelling system containing nepafenac loaded silica nanoparticle could be a promising tool for the topical delivery of drugs to the eye. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:336 / 345
页数:10
相关论文
共 43 条
  • [1] Liposomes in topical ophthalmic drug delivery: an update
    Agarwal, Renu
    Iezhitsa, Igor
    Agarwal, Puneet
    Nasir, Nurul Alimah Abdul
    Razali, Norhafiza
    Alyautdin, Renad
    Ismail, Nafeeza Mohd
    [J]. DRUG DELIVERY, 2016, 23 (04) : 1075 - 1091
  • [2] Optimization and evaluation of thermoresponsive diclofenac sodium ophthalmic in situ gels
    Asasutjarit, Rathapon
    Thanasanchokpibull, Suthira
    Fuongfuchat, Asira
    Veeranondha, Sukitaya
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 411 (1-2) : 128 - 135
  • [3] Synthesis of SiO2 Nanostructures Using Sol-Gel Method
    Azlina, H. N.
    Hasnidawani, J. N.
    Norita, H.
    Surip, S. N.
    [J]. ACTA PHYSICA POLONICA A, 2016, 129 (04) : 842 - 844
  • [4] A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye
    Baba, Koichi
    Tanaka, Yuji
    Kubota, Akira
    Kasai, Hitoshi
    Yokokura, Shunji
    Nakanishi, Hachiro
    Nishida, Kohji
    [J]. JOURNAL OF CONTROLLED RELEASE, 2011, 153 (03) : 278 - 287
  • [5] Optimization of thermoreversible poloxamer gel system using QbD principle
    Ban, Eunmi
    Jang, Dong-Jin
    Kim, Su-Jin
    Park, Mijung
    Kim, Aeri
    [J]. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2017, 22 (07) : 939 - 945
  • [6] Preparation and Evaluation of Novel In Situ Gels Containing Acyclovir for the Treatment of Oral Herpes Simplex Virus Infections
    Chaudhary, Binu
    Verma, Surajpal
    [J]. SCIENTIFIC WORLD JOURNAL, 2014,
  • [7] Surface activity of water soluble amphiphilic chitin derivatives
    Desbrieres, J
    Rinaudo, M
    Babak, V
    Vikhoreva, G
    [J]. POLYMER BULLETIN, 1997, 39 (02) : 209 - 215
  • [8] Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)
    Diebold, Yolanda
    Jarrin, Miguel
    Saez, Victoria
    Carvalho, Edison L. S.
    Orea, Maria
    Calonge, Margarita
    Seijo, Begona
    Alonso, Maria J.
    [J]. BIOMATERIALS, 2007, 28 (08) : 1553 - 1564
  • [9] Ghadi A, 2014, CASP J INTERN MED, V5, P156
  • [10] Modified chitosan hydrogels as drug delivery and tissue engineering systems: present status and applications
    Giri, Tapan Kumar
    Thakur, Amrita
    Alexander, Amit
    Ajazuddin
    Badwaik, Hemant
    Tripathi, Dulal Krishna
    [J]. ACTA PHARMACEUTICA SINICA B, 2012, 2 (05) : 439 - 449